Avital Bareket-Samish

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Epithelial Mesenchymal Transition

Cystic Fibrosis

Top Venues

Purinergic signalling

The breast journal

This page only lists publications with an associated author ORCID identifier.

Publications

Ohad Etzion, Avital Bareket-Samish, David Yardeni, Pnina Fishman
Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma. Biomedicines 12 (4) (2024)
Ohad Etzion, Avital Bareket-Samish, David Yardeni, Pnina Fishman
Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma. Biomedicines 12 (4) (2024)
Pnina Fishman, Salomon M Stemmer, Avital Bareket-Samish, Michael H Silverman, William D Kerns
Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepatoprotective effects. Purinergic signalling (2023)
Gil Bar-Sela, Yousef Samih, Rinat Yerushalmi, Michelle Leviov, Noa Efrat Ben-Baruch, Iryna Kuchuk, Margarita Tokar, Tamar Peretz-Yablonski, Amir Sonnenblick, Lior Soussan-Gutman, Avital Bareket-Samish, Georgeta Fried, Shani Paluch-Shimon, Bella Kaufman, Ariel Hammerman, Nicky Liebermann, Salomon M Stemmer
Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2-negative breast cancer patients in Israel: A registry analysis. The breast journal 26 (10) (2020)